Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
56,728,151
-
Share change
-
-13,148
-
Total reported value
-
$7,039,068,770
-
Put/Call ratio
-
140%
-
Price per share
-
$123.97
-
Number of holders
-
465
-
Value change
-
-$22,114,573
-
Number of buys
-
203
-
Number of sells
-
214
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2023
As of 30 Jun 2023,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
465 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,728,151 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, LSV ASSET MANAGEMENT, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, SAMLYN CAPITAL, LLC, Polaris Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and Deep Track Capital, LP.
This page lists
465
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.